1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC
  6. CytoDyn Inc (QB) (CYDY)
  7. News

CYDY

CytoDyn (QB) News

Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
Small Cap Pro
Monthly Subscription
for only
$49.05
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
VAT not included
Company Name Stock Ticker Symbol Market Type
CytoDyn Inc (QB) CYDY OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 1.25 07:55:42
Open Price Low Price High Price Close Price Prev Close
1.25
more quote information »

Recent News

Date Time Source Heading
12/01/20218:24IHNWFeaturedGraphite prices heading higher on market tightness
12/01/20218:00IHNWFeaturedInnerScope Hearing Technologies (OTC: INND) Partners with Giant Eagle to Deploy Hearing Screening Kiosks
11/30/202112:32IHNWFeaturedDEFENCE THERAPEUTICS VACCINES AND PROGRAM DEVELOPMENT
11/30/202110:07IHNWFeaturedCybin Announces FDA Investigational New Drug and Institutional Review Board Approvals for a Co-Funded Phase 2 Clinical Trial to Treat Frontline Clinicians Experiencing COVID-Related Distress
11/30/202118:32EDGARAmended Statement of Changes in Beneficial Ownership (4/a)
11/30/202118:32EDGARAmended Statement of Changes in Beneficial Ownership (4/a)
11/30/202118:31EDGARAmended Statement of Changes in Beneficial Ownership (4/a)
11/29/202118:30EDGARStatement of Changes in Beneficial Ownership (4)
11/29/202118:27EDGARStatement of Changes in Beneficial Ownership (4)
11/29/202118:20EDGARStatement of Changes in Beneficial Ownership (4)
11/24/202117:22EDGARCurrent Report Filing (8-k)
11/24/202116:05EDGARCurrent Report Filing (8-k)
11/24/202110:08SEEKCytoDyn reports leronlimab data in NASH trial for first 15..
11/23/202117:24EDGARCurrent Report Filing (8-k)
11/22/202109:38IHNWSA Breaking News - PURA estimates $1M in 2022 revenue
11/19/202108:50IHNWPURA BULLISH RESURGANCE
11/17/202106:02EDGARCurrent Report Filing (8-k)
11/16/202107:07SEEKCytoDyn submits the first section of HIV BLA to FDA under..
11/09/202116:55EDGARCurrent Report Filing (8-k)
11/08/202107:50SEEKCytoDyn submits leronlimab Breakthrough Therapy designation..
11/05/202111:30EDGARAdditional Proxy Soliciting Materials - Non-management..
11/03/202106:11SEEKCytoDyn posts preliminary results from mid-stage leronlimab..
10/29/202114:31IHNWiQSTEL, Inc. - The Calm Before The Surge (OTCQX: IQST)
10/28/202114:06EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
10/28/202113:58EDGARCurrent Report Filing (8-k)
10/27/202116:27EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
10/21/202116:10EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
10/21/202116:07EDGARCurrent Report Filing (8-k)
10/20/202117:28EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
10/20/202116:21EDGARStatement of Changes in Beneficial Ownership (4)
10/20/202116:17EDGARStatement of Changes in Beneficial Ownership (4)
10/20/202116:11EDGARStatement of Changes in Beneficial Ownership (4)
10/20/202116:10EDGARStatement of Changes in Beneficial Ownership (4)
10/20/202116:09EDGARStatement of Changes in Beneficial Ownership (4)
10/18/202116:22EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
10/18/202116:17EDGARCurrent Report Filing (8-k)
10/14/202117:08EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
10/14/202109:27EDGARProxy Statment - Contested Solicitations (definitive)..
10/07/202106:05EDGARNotice of Effectiveness (effect)
10/07/202106:04EDGARProxy Soliciting Materials (revised) (prer14a)
10/06/202117:17EDGARCurrent Report Filing (8-k)
10/06/202106:01EDGARProxy Statement - Non-management (definitive, Revised)..
10/04/202109:36EDGARAdditional Proxy Soliciting Materials - Non-management..
9/30/202109:31EDGARAdditional Proxy Soliciting Materials - Non-management..
9/29/202117:16EDGARCurrent Report Filing (8-k)
9/29/202106:09EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
9/29/202106:07EDGARCurrent Report Filing (8-k)
9/28/202117:17EDGARAmended Annual Report (10-k/a)
9/28/202110:02EDGARAdditional Proxy Soliciting Materials - Non-management..
9/24/202110:11EDGARAdditional Proxy Soliciting Materials - Non-management..
9/22/202116:08EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
9/22/202116:06EDGARCurrent Report Filing (8-k)
9/21/202109:31EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
9/21/202109:30EDGARCurrent Report Filing (8-k)
See more news about this stock »


Your Recent History
USOTC
CYDY
CytoDyn (Q..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.